NPB 06

Drug Profile

NPB 06

Alternative Names: NPB-06

Latest Information Update: 14 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nihon Pharmaceutical
  • Class
  • Mechanism of Action Blood coagulation factor inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Phase III Venous thrombosis

Most Recent Events

  • 20 Oct 2017 NPB 06 is still undergoing phase III development for Venous thrombosis in Japan
  • 20 Oct 2017 Efficacy data from a phase III trial in Venous thrombosis presented at the 68th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD-2017)
  • 31 Mar 2017 No recent reports of development identified - Phase-III for Venous thrombosis in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top